Bloomlife, founded in 2014, builds FDA-cleared wearable sensors and a connected care platform for continuous remote monitoring of maternal-fetal health. The company's technical work spans wearable sensor development, cellular-enabled devices, cloud-based analytics, EMR integration and smart notifications - a stack designed to collect physiological data at home and turn it into clinically usable information. The engineering challenges are those of data-driven healthcare at scale: reliable signal acquisition, automated analysis and integration with existing clinical systems.
The company sells its technology as a B2B2C remote patient monitoring solution for high-risk pregnancies. Its product, Bloomlife Connects, is a turnkey monitoring program that plugs into clinical workflows and EMR systems to automate data collection and analysis. The accompanying wearable sensors monitor blood pressure, blood glucose and fetal health continuously from the patient's home.
Bloomlife reports clinically validated outcomes for its programmes: a 260% improvement in screening adherence, 61% fewer preeclampsia cases and an 80% lower stillbirth rate among high-risk patients. The company's stated focus is on saving clinical staff time and improving patient confidence, and its technology has received industry awards. Bloomlife works with healthcare organisations across the United States.
